207 related articles for article (PubMed ID: 16720205)
1. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy.
Luque J; Torres MI; Aumente MD; Marín J; García-Jurado G; González R; Pascual D; Guerra N; López-Rubio F; Alvarez-López MR; Arizón JM; Peña J
Hum Immunol; 2006; 67(4-5):257-63. PubMed ID: 16720205
[TBL] [Abstract][Full Text] [Related]
2. sHLA-G levels in the monitoring of immunosuppressive therapy and rejection following heart transplantation.
Luque J; Torres MI; Aumente MD; Lozano JM; García-Jurado G; González R; Alvarez-López MR; Arizón JM; Peña J
Transpl Immunol; 2006 Dec; 17(1):70-3. PubMed ID: 17157221
[TBL] [Abstract][Full Text] [Related]
3. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation.
Rebmann V; Bartsch D; Wunsch A; Möllenbeck P; Golda T; Viebahn R; Grosse-Wilde H
Hum Immunol; 2009 Dec; 70(12):995-9. PubMed ID: 19651178
[TBL] [Abstract][Full Text] [Related]
4. 14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring.
Torres MI; Luque J; Lorite P; Isla-Tejera B; Palomeque T; Aumente MD; Arizon J; Peña J
Hum Immunol; 2009 Oct; 70(10):830-5. PubMed ID: 19638290
[TBL] [Abstract][Full Text] [Related]
5. [Expression of human leucocyte antigen G in peripheral blood of kidney transplantation recipients].
Xiao L; Shi BY; Cai M; He XY; Xu XG; Han Y; Zhou WQ; Meng XY; Gao Y
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(4):241-4. PubMed ID: 20356537
[TBL] [Abstract][Full Text] [Related]
6. Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.
Sheshgiri R; Rouas-Freiss N; Rao V; Butany J; Ramzy D; Krawice-Radanne I; Ross HJ; Carosella ED; Delgado DH
J Heart Lung Transplant; 2008 May; 27(5):522-7. PubMed ID: 18442718
[TBL] [Abstract][Full Text] [Related]
7. Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients.
Sheshgiri R; Gustafsson F; Sheedy J; Rao V; Ross HJ; Delgado DH
J Heart Lung Transplant; 2009 Nov; 28(11):1193-7. PubMed ID: 19783164
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of sHLA-G-mediated with better graft acceptance in early posttransplantation.
Jin HL; Li CR; Xiao L; Shi BY; Cai M; Li ZL; Wang S; Chen LP; Zhan SL; Li PC
Transplant Proc; 2012 Jun; 44(5):1259-61. PubMed ID: 22663996
[TBL] [Abstract][Full Text] [Related]
9. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
[TBL] [Abstract][Full Text] [Related]
10. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.
Girnita AL; McCurry KR; Iacono AT; Duquesnoy R; Corcoran TE; Awad M; Spichty KJ; Yousem SA; Burckart G; Dauber JH; Griffith BP; Zeevi A
J Heart Lung Transplant; 2004 Oct; 23(10):1135-41. PubMed ID: 15477106
[TBL] [Abstract][Full Text] [Related]
11. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
12. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients.
Twito T; Joseph J; Mociornita A; Rao V; Ross H; Delgado DH
J Heart Lung Transplant; 2011 Jul; 30(7):778-82. PubMed ID: 21482149
[TBL] [Abstract][Full Text] [Related]
13. Increased concentration of soluble human leukocyte antigen class I levels in the bronchoalveolar lavage of human pulmonary allografts.
Rizzo M; Sundaresan S; Lynch J; Trulock EP; Cooper J; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 1997 Nov; 16(11):1135-40. PubMed ID: 9402513
[TBL] [Abstract][Full Text] [Related]
14. Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release.
Morandi F; Levreri I; Bocca P; Galleni B; Raffaghello L; Ferrone S; Prigione I; Pistoia V
Cancer Res; 2007 Jul; 67(13):6433-41. PubMed ID: 17616704
[TBL] [Abstract][Full Text] [Related]
15. Detection of soluble HLA-G and its correlation with kidney transplant outcome.
Kaneku H
Clin Transpl; 2006; ():447-54. PubMed ID: 18365402
[TBL] [Abstract][Full Text] [Related]
16. Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival.
Ballantyne CM; Mainolfi EA; Young JB; Windsor NT; Cocanougher B; Lawrence EC; Pollack MS; Entman ML; Rothlein R
J Heart Lung Transplant; 1994; 13(4):597-603. PubMed ID: 7947875
[TBL] [Abstract][Full Text] [Related]
17. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation.
Aumente MD; Arizón JM; Segura J; López A; Albornoz R; Cárdenas M; Segura C
Transplant Proc; 2005 Nov; 37(9):4014-7. PubMed ID: 16386613
[TBL] [Abstract][Full Text] [Related]
18. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen-G expression after kidney transplantation is associated with a reduced incidence of rejection.
Crispim JC; Duarte RA; Soares CP; Costa R; Silva JS; Mendes-Júnior CT; Wastowski IJ; Faggioni LP; Saber LT; Donadi EA
Transpl Immunol; 2008 Feb; 18(4):361-7. PubMed ID: 18158124
[TBL] [Abstract][Full Text] [Related]
20. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
